REPRIEVE final results: What does it mean for guidelines in low‐ and middle‐income countries?
Abstract Introduction The REPRIEVE study demonstrated significant reductions in major adverse cardiovascular events (MACE) with pitavastatin among people living with HIV (PWH) with low to moderate cardiovascular risk. Most MACE events occurred in higher‐income countries, raising important considerat...
Saved in:
| Main Authors: | Simiso Sokhela, Jennifer M. Manne‐Goehler, Samanta Lalla‐Edward, Mark J. Siedner, Mohammed K. Ali, Andrew Hill, Aaloke Mody, Anton Pozniak, Jeremy Nel, W. D. Francois Venter |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Journal of the International AIDS Society |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jia2.26525 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin
by: Berezin A.E., et al.
Published: (2015-06-01) -
Primary dyslipidemia and cardiometabolic risk: potential of pitavastatin.
by: A. E. Berezin, et al.
Published: (2015-06-01) -
Acute effect of statins on vascular reactivity in maternal and placental arteries from pregnancies complicated by preeclampsia
by: Chinedu Agwu, et al.
Published: (2025-06-01) -
The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists
by: Marina G. Bubnova, et al.
Published: (2025-01-01) -
Interdisciplinary Expert Consensus: the place of original pitavastatin in primary and secondary prevention of cardiovascular diseases
by: M. G. Bubnova, et al.
Published: (2024-12-01)